生命科学资讯

Pfizer's $10B monthly GLP-1 bet generates competitive weight loss in phase 2b

Daiichi ends work on an ADC; Layoffs at GSK's R&D unit

FDA launches ‘PreCheck’ program; AstraZeneca, Acadia drugs set back

Illumina Partners with San Diego Zoo for Genomic Sequencing of Endangered Species - Intellectia AI

Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally - PR Newswire

Ultragenyx unwraps data that may be central to its gene therapy resubmission

Agilent Technologies : and Virscidian Announce Collaboration to Streamline Access to OpenLab CDS Data in Analytical Studio - marketscreener.com

Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings

Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months

45% earnings growth over 1 year has not materialized into gains for Lonza Group (VTX:LONN) shareholders over that period - Yahoo Finance

Investors crave safer, market-ready biotech bets, widening the early-stage funding gap

Mirum doubles down on diversified rare disease strategy

AstraZeneca gets CRL for prefilled pen version of lupus drug Saphnelo

NMD flunks rare disease trial but flexes secondary data to accelerate program

Quest launches residual disease blood test for multiple myeloma

Earnings call transcript: Lonza misses Q4 2025 forecasts, stock drops 9% - Investing.com

Strengthening Families & Communities LLC Purchases 4,825 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Thermo Fisher to close Franklin MA plant; more than 100 jobs affected - Milford Daily News

Mediolanum International Funds Ltd Sells 15,620 Shares of Agilent Technologies, Inc. $A - MarketBeat

How Mirum is Advancing Rare Disease Care Through Strategic M&A